ruxolitinib
novartis,incyte
['ruxolitinib', 'rux,(-crux),(-trux),(-deruxtecan)']
dr. locatelli: ruxolitinib with pred in pediatric agvhd, 70% steroid refractory, orr 84% at d28, and 90% in steroid refractory, at day 56 it is 66%, reach4 study, definitely an option for kids! #ash22 
Hem/Onc, BMT, CAR-T, Immunology, Math, Machine Learning, Python, R, SAS. Tweets are my personal views